Influenza hemagglutinin and neuraminidase antigens — Drug Target

All drugs that target Influenza hemagglutinin and neuraminidase antigens — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

mRNA vaccine · Quadrivalent influenza vaccine

Phase 3 pipeline (2)

• Influsplit® Tetra · ModernaTX, Inc. · mRNA vaccine · Immunology / Infectious Disease
  Influsplit® Tetra is a quadrivalent mRNA vaccine that encodes influenza virus surface antigens to stimulate immune responses against four strains of influenza.
• Quadrivalent VLP Influenza Vaccine · Medicago · Quadrivalent influenza vaccine · Immunology / Infectious Disease
  A plant-based virus-like particle (VLP) vaccine that presents influenza surface antigens to stimulate immune responses against four influenza virus strains.